Læknablaðið - 15.08.1991, Qupperneq 34

240
LÆKNABLAÐIÐ
and thyroxine in one resulting in alleviation
of menstrual irregularities, 25 pregnancies and
19 living babies, and disappearance of acute
headaches and visual disturbances. Presently 14
women continue bromocriptine therapy, and one
remains on thyroxine lifelong. Adverse affects of
bromocriptine therapy were very common with
only three women reporting no ill affects and
twice side affects were so severe as to necessitate
discontinuation of treatment.
HEIMILDIR
1. Schwartz TB. What you always wanted to know
about prolactin - But were afraid to ask. Yearbook
of Endocrinology. Chicago: Yearbook Medical
Publishers Inc., 1973; 7-24.
2. Guinet P, Girot C, Pousset G, Trouillas J, L’Hermite
M. Un cas d’adenome á cellulaes á prolactine: dosage
de prolactine, étude au microscope électronique,
resultats post-operatoires. Ann Endocrinol 1973; 1:
407-17.
3. Guyda H, Robert F, Colle E, Hardy J. Histologic,
ultrastrucural and hormonal characterization of a
pituitary secreting both HGH and prolactin. J Clin
Endocrinol 1973; 36: 531-47.
4. Vance ML, Thomer MO. PROLACTIN.
Hyperprolactinemic syndromes and management. In:
DeGroot LJ, ed. Endocrinology. 2nd ed. Philadelphia,
London, Toronto, Montreal, Sidney, Tokyo: WB
Saunders, 1989: 408-18.
5. Vezina JL, Sutton TJ. Prolactin secreting pituitary
microadenoma. Roentgenologic diagnosis. Am J
Roentgenol 1974; 120: 46-51.
6. Edwards CRW, Forsyth IE, Besser GM. Amenorrhea,
galactorrhea and primary hypothyroidism with high
circulating levels of prolactin. BMJ 1971; 3: 462-4.
7. Riddle O, Bates RW, Dykshom SW. The preparation,
identification and assey of prolactin - a hormone of
the anterior pituitary. Am J Physiol 1933; 105: 191-
216.
8. Hwang P, Guyda H, Friesen H. A radioimmune assey
for human prolactin. Proc Natl Acad Sci 1971; 68:
1902-6.
9. Hwang P, Guyda P, Friesen H. Purification of human
prolactin. J Biol Chem 1972; 247: 1955-8.
10. Kjeld M. Munnlegar upplýsingar um
mælingaraðferðir.
11. Fliickiger E, Wagner H. 2-Br-alfa-ergokryptin;
Beeinfliissung von Fartilitat und Laktation bei der
Ratte. Experentia 1968; 24: 1130-1.
12. McNeilly AS, Besser GM. Abnormalities of prolactin
secretion. Postgraduate course in endocrinology,
London 1972.
13. Hilmarsdóttir I, Guðmundsson SÞ. Frumeinkenni og
famaður 20 kvenna með ofgnótt mjólkurhormóns í
blóði frá 1. apríl 1977 til 31. mars 1986. f: Útdrættir
úr erindum fluttum á VII. þingi Félags íslenskra
lyflækna á Akureyri 30. maí til 1. júní 1986.
Læknablaðið 1986; 72: 364.
14. Hardy J. Transsphenoidal surgery of hypersecreting
pituitary tumors. Diagnosis and treatment of
pituitary tumors. Proceedings of a conference held in
Bethesda, Md., USA. Amsterdam: Excerpta Medica,
1973: 179-84.
15. Thomer MO, Besser GM. Bromocriptine treatment of
hyperprolactinemic hypogonadism. Acta Endocrinol
1978; 216/Suppl. 88: 131-46.
16. Franks S, Nabarro JDN, Jacobs HS. Prevalence and
presentation of hyperprolactinemia in patients with
»functionless« pituitary tumours. Lancet 1978; 1:
778-80.
17. Kemmann J, Jones JR. Hyperprolactinemia and
headaches. Am J Obstet Gynecol 1983; 145/6: 668-
71.
18. Doyle HF. Radiology in metabolic bone disease.
Postgraduate course in endocrinology, London 1972.
19. Hull MGR, Bromham DR, Savage PE, Barlow TM,
Hughes AO, Jacobs HS. Post-pill amenorrhea: A
causal study. Fertil Ster 1981; 36: 472-6.
20. Coulam CB, Annegers JF, Abboud CF, Laws ER jr,
Kunland LT. Pituitary adenoma and contraceptives. A
case control study. Fertil Steril 1979; 31: 25-8.
21. Halse J, Jervell J, Kjartansson O, Hansen E,
Kollevold T. Bromokriptinbehandling av store
prolaktinomer. Tidsskr Nor Lægeforen 1986; 106:
328-31.
22. Bonneville J-F, Poulignot D, Cattin F, Mollet E,
Dietmann J-L. Computed tomographic demonstration
of the effects of bromocriptine on pituitary
microadenoma size. Radiology 1982: 143: 451-5.
23. Burrow GN, Wortzman G, Rewcastle NB, Holgate
RC, Kovacs K. Microadenomas of the pituitary and
abnormal sellar tomograms in an unselected autopsy
series. N Engl J Med 1981; 304: 156-8.
24. Boulanger CM, Mashak CA, Chang RJ. Lack of
tumor reduction in hyperprolactinemic women
with extrasellar macroadenomas treated with
bromocriptine. Fertil Steril 1985; 44: 532-5.